Received: 26 February 2020
Accepted: 17 September 2020
First Online: 1 October 2020
Ethics approval and consent to participate
: The trial was evaluated by the Ethics committee of the Medical faculty of the University of Heidelberg (S-203/2019). All patients must declare their informed consent to participate in the trial in written form before enrollment.
: No individual person’s data is used in the manuscript.
: Juergen Debus received grants from Merck Serono GmbH, The Clinical Research Institute GmbH (CRI), View Ray Inc., Accuray Incorporated, RaySearch Laboratories AB, Vision RT limited, Astellas Pharma GmbH, Astra Zeneca GmbH, Solution Akademie GmbH, Ergomed PLC Surrey Research Park, Siemens Healthcare GmbH, Quintiles GmbH, Pharmaceutical Research Associates GmbH, Boehringer Ingelheim Pharma GmbH Co, PTW-Freiburg Dr. Pychlau GmbH and Nanobiotix A.A. outside the submitted work. The authors declare that they have no competing interests.